Search results
Moderna COVID vaccine sales plummet 91 percent - The Boston Globe
The Boston Globe· 1 hour agoSales of Moderna’s COVID-19 vaccine plunged 91 percent from the previous year for the first quarter...
Moderna revenues plummeted after sales of its COVID-19 vaccine fell 91%
Quartz· 4 hours agoModerna’s first-quarter revenue was slashed nearly in half over the course of a year as sales of its...
Moderna posts quarterly sales beat, smaller loss than expected
Reuters via Yahoo Finance· 6 hours ago(Reuters) -Moderna on Thursday reported quarterly revenue that beat Wall Street estimates but came...
Moderna Stock Jumps After Scoring an Earnings Beat. Next Up? Its RSV Shot.
Barrons.com· 2 hours agoModerna reported first-quarter financial results Thursday that soundly beat Wall Street...
Moderna Inc (MRNA) Q1 2024 Earnings: Significant Revenue Decline Amid Strategic Shifts
GuruFocus.com via Yahoo Finance· 5 hours agoModerna's programs cover infectious diseases, oncology, cardiovascular diseases, and rare genetic...
Moderna Reports First Quarter 2024 Financial Results and Provides Business Updates
Digital Journal· 6 hours agoReports first quarter revenues of $167 million, GAAP net loss of $1.2 billion and GAAP diluted EPS of $(3.07)Prepares for launches of RSV vaccine and Spikevax< ...
The Dow rises 220 points with all eyes on Apple earnings
Quartz· 59 minutes agoThe Dow Jones and other major stock indexes opened higher a day after the Fed confirmed that there...
Moderna (MRNA) Set to Announce Earnings on Thursday
ETF DAILY NEWS· 1 day agoModerna (NASDAQ:MRNA – Get Free Report) will be releasing its earnings data before the market opens on Thursday, May 2nd. Analysts expect Moderna to post ...
Why are nearly half of all recent biotech RNA alliances in Asia-Pacific betting big on...
BioPharma-Reporter· 2 days agoAlmost half of all strategic alliances focused on RNA therapies over the last five years in the...
Shhh! 3 Secret Biotech Stocks Flying Below Wall Street's Radar
InvestorPlace· 22 hours agoBiotech stocks are full of intriguing innovators who could help pave the way for greater gains over...